We are only able to display limited information for this firm. We display more complete information for all of the following firms:

Spearheaded by dual English-French qualified Denis Schertenleib, who has a background in physics and molecular neurobiology, the team at Cabinet Schertenleib has a wealth of experience handling complex litigation before the EPO, French courts, and the UPC. The firm has a specific penchant for advising large multinational pharmaceutical companies on their medical patent infringement, validity, and enforcement issues, and the group also handles filings. Marc Lauzeral is also a key name in the team, as well as Ombeline Degrèze-Péchade; both are seasoned litigators with significant pharmaceutical expertise.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Excellent firm, with a great specialisation in IP. Also has understanding of UK/US clients.’
  • ‘Excellent individual lawyers.’

Abbreviated data is displayed for this firm.

Key clients

  • Recor Medical Inc. & Otsuka Medical Device
  • Viatris
Abbreviated data is displayed for this firm.